<?xml version="1.0" encoding="UTF-8"?>
<p id="Par37">Chikungunya specific antibodies in this study was 27.69%. IgM was positive in 10.39% (n = 27/260) and IgG in 20.76% (n = 54/260). A similar study in Nigeria and Benin reported 13% and 36.1% of anti-Chikungunya IgG antibodies respectively compared to 20.76% in Ghana [
 <xref ref-type="bibr" rid="CR20">20</xref>, 
 <xref ref-type="bibr" rid="CR21">21</xref>]. Anti-Chikungunya IgM antibodies of 10.39% in our study may suggest recent infections, notwithstanding, subclinical or possibly apparent that might have been missed and undiagnosed or treated as any common endemic ailment. We observed less prevalence in anti-CHIKV antibodies (27.69%) than anti-DENV (69.23%) which corroborates other seroprevalence studies in Africa [
 <xref ref-type="bibr" rid="CR22">22</xref>, 
 <xref ref-type="bibr" rid="CR23">23</xref>].
</p>
